Cargando…
MRI for breast cancer: Current indications
Mammography is the only imaging study that has been proven in multiple large randomized trials to decrease breast cancer mortality. Mammography, however, has its limitations and, as such, other modalities that can complement it are being studied. One of these is dynamic contrast-enhanced breast MRI,...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765174/ https://www.ncbi.nlm.nih.gov/pubmed/19881077 http://dx.doi.org/10.4103/0971-3026.48431 |
_version_ | 1782173136660201472 |
---|---|
author | Ojeda-Fournier, Haydee Comstock, Christopher E |
author_facet | Ojeda-Fournier, Haydee Comstock, Christopher E |
author_sort | Ojeda-Fournier, Haydee |
collection | PubMed |
description | Mammography is the only imaging study that has been proven in multiple large randomized trials to decrease breast cancer mortality. Mammography, however, has its limitations and, as such, other modalities that can complement it are being studied. One of these is dynamic contrast-enhanced breast MRI, which has emerged as an important adjunctive modality and is at present the most sensitive modality that we have to evaluate the breast. The American College of Radiology, in its 2004 practice guidelines, has outlined the 12 current indications for breast MRI. This manuscript reviews and provides examples of each of these. |
format | Text |
id | pubmed-2765174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-27651742009-11-20 MRI for breast cancer: Current indications Ojeda-Fournier, Haydee Comstock, Christopher E Indian J Radiol Imaging Special Symposium - Breast Mammography is the only imaging study that has been proven in multiple large randomized trials to decrease breast cancer mortality. Mammography, however, has its limitations and, as such, other modalities that can complement it are being studied. One of these is dynamic contrast-enhanced breast MRI, which has emerged as an important adjunctive modality and is at present the most sensitive modality that we have to evaluate the breast. The American College of Radiology, in its 2004 practice guidelines, has outlined the 12 current indications for breast MRI. This manuscript reviews and provides examples of each of these. Medknow Publications 2009-05 /pmc/articles/PMC2765174/ /pubmed/19881077 http://dx.doi.org/10.4103/0971-3026.48431 Text en © Indian Journal of Radiology and Imaging http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Special Symposium - Breast Ojeda-Fournier, Haydee Comstock, Christopher E MRI for breast cancer: Current indications |
title | MRI for breast cancer: Current indications |
title_full | MRI for breast cancer: Current indications |
title_fullStr | MRI for breast cancer: Current indications |
title_full_unstemmed | MRI for breast cancer: Current indications |
title_short | MRI for breast cancer: Current indications |
title_sort | mri for breast cancer: current indications |
topic | Special Symposium - Breast |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765174/ https://www.ncbi.nlm.nih.gov/pubmed/19881077 http://dx.doi.org/10.4103/0971-3026.48431 |
work_keys_str_mv | AT ojedafournierhaydee mriforbreastcancercurrentindications AT comstockchristophere mriforbreastcancercurrentindications |